View Author
dai: 241458358
scopus: 15033340900

Huisman, W.

(Willem Huisman)


worden bedrijven wordt virus milieu bedrijf ondernemingen heeft kunnen naleving tussen onderneming infection andere binnen regelnaleving organisatie hebben regel onderzoek overtreding antibody volgen vaccine overheid handhaving vergunning winst protein regelgeving voorschriften onder afval verschillende envelope wettelijke echter moraal gedrag normen immunode ficiency virus omgeving challenge bedrijfsinterne vooral verschillen wanneer vaccination group naleving van milieu waarin bijvoorbeeld immunodeficiency bepaalde sprake werknemer immunodeficiency virus afvalstoffen tegen kosten ficiency maken belang virol immunode branche sociale alleen goede grote belangrijke enkele regelovertreding arbozorg response corporation vaccinated wijze enhancement aanzien




10 Most Recent Publications

Domain- and nucleotide-specific Rev response element regulation of feline immunodeficiency virus production (Article)
Na, H. Huisman, W. Ellestad, K.K. Phillips, T.R. Power, C.
2010-09-01
Vaccine-induced enhancement of viral infections (Article)
Huisman, W. Martina, B.E.E. Rimmelzwaan, G.F. Gruters, R.A. Osterhaus, A.D.M.E.
2009-01-22
Evaluation of vaccination strategies against infection with feline immunodeficiency virus (FIV) based on recombinant viral vectors expressing FIV Rev and OrfA (Article)
Huisman, W. Schrauwen, E.J. Tijhaar, E.J. Süzer, Y. Pas, S.D. Amerongen, G. van Sutter, G. Rimmelzwaan, G.F. Osterhaus, A.D.M.E.
2008-12-15
Intrahost evolution of envelope glycoprotein and OrfA sequences after experimental infection of cats with a molecular clone and a biological isolate of feline immunodeficiency virus (Article)
Huisman, W. Schrauwen, E.J. Rimmelzwaan, G.F. Osterhaus, A.D.M.E.
2008-10-01
Evaluation of ISCOM-adjuvanted subunit vaccines containing recombinant feline immunodeficiency virus Rev, OrfA and envelope protein in cats (Article)
Huisman, W. Schrauwen, E.J. Pas, S.D. Amerongen, G. van Rimmelzwaan, G.F. Osterhaus, A.D.M.E.
2008-05-19
Antibodies specific for hypervariable regions 3 to 5 of the feline immunodeficiency virus envelope glycoprotein are not solely responsible for vaccine-induced acceleration of challenge infection in cats (Article)
Huisman, W. Schrauwen, E.J. Pas, S.D. Karlas, J.A. Rimmelzwaan, G.F. Osterhaus, A.D.M.E.
2004-07-01
Antibodies specific for hypervariable regions 3 to 5 of the feline immunodeficiency virus envelope glycoprotein are not solely responsible for vaccine-induced acceleration of challenge infection in cats (Article)
Huisman, W. Schrauwen, E.J. Pas, S.D. Karlas, J.A. Rimmelzwaan, G.F. Osterhaus, A.D.M.E.
2004-01-01
Tussen winst en moraal. Achtergronden van regelnaleving en regelovertreding door ondernemingen. (Doctoral Thesis)
Huisman, W.
2001-03-08
Vaccination with experimental feline immunodeficiency virus vaccines, based on autologous infected cells, elicits enhancement of homologous challenge infection. (Article)
Karlas, J.A. Siebelink, C.H.J. Peer, M.A. van Huisman, W. Cuisinier, A.M. Rimmelzwaan, G.F. Osterhaus, A.D.M.E.
1999-01-01
Vaccination with experimental feline immunodeficiency virus vaccines, based on autologous infected cells, elicits enhancement of homologous challenge infection (Article)
Karlas, J.A. Siebelink, C.H.J. Peer, M.A. Huisman, W. Cuisinier, A.M. Rimmelzwaan, G.F. Osterhaus, A.D.M.E.
1999-01-01
  • rss icon RSS Publication Feed
  • foaf icon FOAF Profile